The global multiple sclerosis market is anticipated to grow at a CAGR of around 2.5% during the forecast period (2021-2027). Multiple sclerosis is a neurological disorder characterized by loss of the myelin sheath. The rising prevalence of MS globally is one of the major factors driving the growth of the market. Many market players such as Bayer […]
